C4 Therapeutics, Inc. (CCCC) stock
CCCCNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/303% above fair value
$2.53−0.12 (-4.53%)
Close on Nov 17, 2026Market cap $311.25MP/E –Yield –
C4 Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
C4 Therapeutics's market cap was $355.20M on Nov 11, 2026, against $201.01M a year earlier. Over the last 5 years it ranged from $73.11M to $1.56B, with a median of $317.76M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $355.20M | +150.7% |
| 2025 | Dec 31, 2025 | $141.67M | -44.2% |
| 2024 | Dec 31, 2024 | $254.03M | -8.7% |
| 2023 | Dec 29, 2023 | $278.32M | -3.6% |
| 2022 | Dec 30, 2022 | $288.81M | -81.5% |
| 2021 | Dec 31, 2021 | $1.56B | +2790.2% |
| 2020 | Dec 31, 2020 | $54.14M | – |
See a number that looks wrong?